ACN
Accenture plc
ACN's fundamentals are strong and it looks cheap: trading at 18x earnings, below its usual 28x. Analysts expect earnings growth.
ACN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ACN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
ACN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $250 | — |
| Current | 18x | $250 | — |
| Cheap | 21x | $285 | +14% |
| Fair | 28x | $381 | +52% |
| Expensive | 33x | $447 | +79% |
Historical ranges are pointers, not guarantees.
ACN's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
ACN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for ACN, with profitability holding steady.
ACN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.67 | +8.2% |
| Q3 2026 | $13.56 | +12% |
| Q2 2026 | $12.52 | -0.3% |
| Q1 2026 | $12.21 | +0.8% |
| Q4 2025 | $12.10 | +1.5% |
| Q3 2025 | $12.15 | +6.3% |
| Q2 2025 | $12.56 | +15% |
| Q1 2025 | $12.11 | +9.8% |
| Q4 2024 | $11.92 | +10% |
ACN earned $13.56 per share over the past year, up 12% from the year before.
ACN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +6.2% |
| Q2 2026 | $18.7B | +5.6% |
| Q1 2026 | $18B | +8.3% |
| Q4 2025 | $18.7B | +6% |
| Q3 2025 | $17.6B | +7.3% |
| Q2 2025 | $17.7B | +7.7% |
| Q1 2025 | $16.7B | +5.4% |
| Q4 2024 | $17.7B | +9% |
ACN's revenue has grown year over year for nine quarters in a row: $18.7B last quarter, up 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +3.7 points |
| Q2 2026 | 17% | +0.1 points |
| Q1 2026 | 14% | +0.3 points |
| Q4 2025 | 15% | -1.3 points |
| Q3 2025 | 12% | -2.7 points |
| Q2 2025 | 17% | +0.8 points |
| Q1 2025 | 13% | +0.5 points |
| Q4 2024 | 17% | +0.9 points |
ACN's operating margin was 15% last quarter, up 3.7 points from the same quarter a year ago.
ACN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.8B | -25% |
| Q2 2026 | $3.6B | +2.4% |
| Q1 2026 | $3.7B | +37% |
| Q4 2025 | $1.5B | +73% |
| Q3 2025 | $3.8B | +20% |
| Q2 2025 | $3.5B | +16% |
| Q1 2025 | $2.7B | +35% |
| Q4 2024 | $870.3M | +103% |
ACN's free cash flow has been positive every quarter for seven years: $11.6B over the past year, up 6.9% from the year before.
ACN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -10.3M shares |
| 1 year | -3.8% | -24.1M shares |
| 3 years | -5.3% | -34M shares |
| 5 years | -6.2% | -40M shares |
| Available history | -6.8% | -44.1M shares |
ACN has 605M diluted shares, down 3.8% from a year ago, with $7.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.3B |
| Q2 2026 | $1.2B |
| Q1 2026 | $1.7B |
| Q4 2025 | $2.3B |
| Q3 2025 | $473.9M |
| Q2 2025 | $1.8B |
| Q1 2025 | $1.4B |
| Q4 2024 | $898.3M |
ACN spent $7.5B buying back its own shares over the past year, up 63% from the year before.
ACN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
ACN has more cash than debt.
ACN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.6 | Neutral |
| Stochastic | 88.9 | Overbought |
ACN's weekly RSI is 68 (neutral) and its Stochastic is 89 (overbought).
ACN PE vs Technology Sector
| Metric | ACN | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 34% below |
| PE % | 10 | 35 | 25 pts below |
ACN is trading at 18x earnings, a 34% discount to the Technology sector's median of 28x.
ACN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $229.0 | 9.2% above |
| 20 week MA | $192.0 | 30% above |
| 50 week MA | $204.9 | 22% above |
| 100 week MA | $250.4 | 0.2% below |
| 200 week MA | $285.4 | 12% below |
ACN has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 12% below its 200-week average.
ACN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $212.2 | $257.3 | +21% |
| 2021 | $257.3 | $403.3 | +57% |
| 2022 | $403.3 | $266.1 | -34% |
| 2023 | $266.1 | $350.9 | +32% |
| 2024 | $350.9 | $356.2 | +1.5% |
| 2025 | $356.2 | $271.1 | -24% |
| 2026 YTD | $271.1 | $250.0 | -7.8% |
ACN has finished higher in four of the last six years. It's down 7.8% so far in 2026.